Barrett’s Esophagus in Patients with Gastroesophageal Reflux Disease

Abstract

Background: Barrett’s esophagus a is metaplasia of normal squamous cells that line the lower part of the esophagus and carries a major risk for adenocarcinoma of esophagus. In Asian population, the prevalence of Barrett’s esophagus and adenocarcinoma are less common than in Western countries but has been increasing.Methods: This is a hospital based descriptive study comprising of 120 consecutive patients with symptoms of gastroesophagial reflux disease belonging to both sexes of any age group. The diagnosis of gastroesophagial reflux disease was based on the symptoms like heart burn and regurgitation. Upper gastrointestinal endoscopy was done in all the patients. Four quadrant biopsies were taken from the esophagogastric junction in suspected case of Barrett’s esophagus. The diagnosis of Barrett’s esophagus was confirmed histopathologically.Results: There were 44.2% males and 55.8% females, age ranging from 22 to 85 years mean being 44.33+13.37. Of them, gastroesophagial reflux disease was mild in 54.16%, moderate in 21.16% and severe in 16.66%. Upper Gastrointestinal endoscopy revealed non erosive gastroesophagial reflux disease in 50%, erosive in 45%, hiatal hernias in 5% and Barrett’s esophagus in 1.6%. Both patients with Barrett’s esophagus were elderly and had short segment (<3cm) involvement with no evidence of dysplasia or adenocarcinoma histopathologically.Conclusions: Endoscopic surveillance with detailed inspection and systematic biopsies is recommended for most patients with Barrett’s esophagus. Esophageal carcinoma if detected should be treated at the earliest.

Endoscopic treatment of cardia lesions: the effects on gastroesophageal reflux disease

“…Patients underwent gastroscopies at the 3-and 6-month post-surgical follow-up. The Los Angeles classification was used to assess the degree of esophageal mucosal damage (20). Grade A damage is defined as one or more region of the mucosa damaged in the esophageal mucosa, with a length less than 5 mm.…”

Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018

“…EGD is the most important diagnostic tool for confirming the diagnosis of GERD. The identification of Barrett's esophagus, mucosal breaks such as esophagitis, hiatal hernia, and biopsies to rule out of malignancy are allowed by EGD [59606162636465].…”

Gastroesophageal reflux disease: a modern view on the problem

“…Даний метод має безперечну перевагу, що полягає в безпосередній оцінці ступеня ураження, а також можливості контролю лікування. Проте використання гістологічного дослідження має і певні труднощі в застосуванні, а самевисока вартість обстеження та відсутність спеціального обладнання [25]. Застосування інвазивних методів має небезпеку травматизації слизової оболонки стравоходу та ризик інфікування Helicobacter pylori.…”